Advertiment
Yin Y, Cao LY, Wu WQ, Li H, Jiang Y, Zhang HF.
Department of Pathology, Anhui Medical University, Hefei 230032, Anhui Province, China. caoliyu@yahoo.com.cn.
AIM: To investigate the expression of vascular endothelial cell growth factor (VEGF) and its receptors Fms-like tyrosine kinase 1 (FLT-1) and fetal liver kinase 1 (FLK-1) in colorectal carcinoma (CRC), and the blocking effects of small interfering RNAs (siRNAs) on VEGF expression in human colorectal cancer HCT116 cells. METHODS: Immunohistochemical staining for VEGF, FLT-1 and FLK-1 proteins was performed in 82 cases of CRC and 14 normal colorectal mucosae. A siRNA targeting VEGF was synthesized and transfected into HCT116 cells using lipofectamine 2000. Immunocytochemical staining and Western blotting analyses were performed to detect the expression of VEGF protein. The suppressive effect of the siRNA on cell proliferation was detected using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltertrazolium bromide (MTT) assay. Cellular apoptosis was detected using flow cytometry (FCM). RESULTS: The expression of VEGF, FLT-1 and FLK-1 in tumor tissues was significantly higher than that in normal tissues (P = 0.008, P = 0.000, P = 0.000). The expression of VEGF was positively correlated with both lymph node metastasis and clinical stage (P = 0.009 and P = 0.025, respectively). Immunocytochemistry showed that the expression of VEGF was weakly positive and Western blotting indicated a significant reduction in VEGF-siRNA cell protein levels. VEGF-siRNA cell growth inhibition was assessed by the MTT assay, and the tumor cell proliferation rate was significantly different at 24, 48, and 72 h after transfection. FCM results showed that the VEGF-siRNA group had an apparent aneuploid peak. CONCLUSION: VEGF, FLT-1 and FLK-1 are associated with colorectal carcinogenesis. siRNA silencing of the VEGF gene suppresses proliferation, and induces apoptosis in HCT116 cells. The results suggest that VEGF may be a new gene therapy target for colorectal cancer.
World J Gastroenterol. 2010 Mar 7;16(9):1086-92.
Related Search
out pocket and VEGF and kidney,
Leave a Reply
Suggested Posts
Potential New Treatment For Kidney Cancer By Specific Inhibition Of Autophagy Yi Y, Cao LY, Wu WQ, Li H, Jia g Y, Zha g HF. Departme t of Pathology, A hui Medical U iversity, Hefei 230032, A hui Provi ce, Chi a. caoliyu@yahoo.com.c . AIM: To i vestigate the expressio of vascular e dothelial cell growth factor (VEGF) a d its receptors Fms-like tyrosi e ki ase 1 (FLT-1) a d fetal liver ki ase 1 (FLK-1) i colorectal carci oma (CRC), a d [...]. Posted March 12th, 2010 | 1:49 am
Treatment Of Gynecologic Cancers Reduced From 5 Weeks To 3 Days Using New Radiation Therapy Yi Y, Cao LY, Wu WQ, Li H, Jia g Y, Zha g HF. Departme t of Pathology, A hui Medical U iversity, Hefei 230032, A hui Provi ce, Chi a. caoliyu@yahoo.com.c . AIM: To i vestigate the expressio of vascular e dothelial cell growth factor (VEGF) a d its receptors Fms-like tyrosi e ki ase 1 (FLT-1) a d fetal liver ki ase 1 (FLK-1) i colorectal carci oma (CRC), a d [...]. Posted March 12th, 2010 | 1:49 am
Joint Clinical Practice Guidelines On Hepatocellular Carcinoma Management To Be Published By EASL-EORTC Yi Y, Cao LY, Wu WQ, Li H, Jia g Y, Zha g HF. Departme t of Pathology, A hui Medical U iversity, Hefei 230032, A hui Provi ce, Chi a. caoliyu@yahoo.com.c . AIM: To i vestigate the expressio of vascular e dothelial cell growth factor (VEGF) a d its receptors Fms-like tyrosi e ki ase 1 (FLT-1) a d fetal liver ki ase 1 (FLK-1) i colorectal carci oma (CRC), a d [...]. Posted March 12th, 2010 | 1:49 am
Potential Strategy Aims To Stimulate The Immune System To Defeat Cancers Yi Y, Cao LY, Wu WQ, Li H, Jia g Y, Zha g HF. Departme t of Pathology, A hui Medical U iversity, Hefei 230032, A hui Provi ce, Chi a. caoliyu@yahoo.com.c . AIM: To i vestigate the expressio of vascular e dothelial cell growth factor (VEGF) a d its receptors Fms-like tyrosi e ki ase 1 (FLT-1) a d fetal liver ki ase 1 (FLK-1) i colorectal carci oma (CRC), a d [...]. Posted March 12th, 2010 | 1:49 am
Roche medicine Avastin receives EU approval for the treatment of women with newly diagnosed, advanced ovarian cancer Yi Y, Cao LY, Wu WQ, Li H, Jia g Y, Zha g HF. Departme t of Pathology, A hui Medical U iversity, Hefei 230032, A hui Provi ce, Chi a. caoliyu@yahoo.com.c . AIM: To i vestigate the expressio of vascular e dothelial cell growth factor (VEGF) a d its receptors Fms-like tyrosi e ki ase 1 (FLT-1) a d fetal liver ki ase 1 (FLK-1) i colorectal carci oma (CRC), a d [...]. Posted March 12th, 2010 | 1:49 am